Global Male Urinary Incontinence Market Size Study, by Product, by Incontinence Type, by Usage, by Distribution Channel, by End-use, and Regional Forecasts 2022-2032

Description

Global Male Urinary Incontinence Market is valued approximately at USD 6.74 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.87% over the forecast period 2024-2032. Male urinary incontinence (UI) is a condition characterized by the involuntary leakage of urine, which can result from various health issues, including neurological disorders, trauma, aging, and prostate problems such as a prostatectomy or an enlarged prostate. This condition severely impacts the quality of life, limiting daily activities and leading to emotional and social challenges, thus fueling the market's growth.

The market for male urinary incontinence is expanding significantly, driven by rising incidences of urological disorders such as cystitis, urinary retention, and benign prostatic hyperplasia (BPH), which lead to bladder dysfunction. The increasing incidence of urinary tract infections (UTIs) and urethral obstructions, along with the aging population, further bolsters industry growth. Male urinary incontinence necessitates effective management strategies to help individuals regain control of their bladder function, thereby improving their quality of life. Also, modern lifestyles, including poor diet, lack of physical activity, and high-stress levels, contribute to the rising incidence of urological disorders. These factors necessitate effective treatments and management solutions, driving the demand for male urinary incontinence products. Advancements in medical technology and diagnostic techniques have facilitated the early detection of urological disorders, enabling prompt intervention and treatment. As public awareness regarding urological disorders and their symptoms increases, more individuals are seeking medical advice, thereby reducing the stigma associated with these conditions and driving market growth.

Europe dominated the male urinary incontinence market with a revenue share of 49.81% in 2022, driven by the increasing prevalence of UI among men, particularly the aging population. The region's robust healthcare infrastructure, growing awareness of treatment options, and adoption of innovative products contribute to the market's growth. Key players in the region are focusing on strategic initiatives such as partnerships, new product launches, and sustainability efforts. North America is expected to advance at the highest CAGR during the forecast period, fueled by the presence of key manufacturers and the rising prevalence of urology disorders, diabetes, and obesity, which increase the risk of bladder disorders in men.

Major market players included in this report are:

Essity
Kimberly-Clark Worldwide Inc.
Attends Healthcare Products, Inc.
ABENA
Coloplast Corp.
Teleflex Incorporated
Boston Scientific Corporation
Ontex Healthcare
PAUL HARTMANN AG
First Quality
Medline
Hollister Incorporated
Cook Medical Incorporated
F. Hoffmann-La Roche AG
AstraZeneca plc.

The detailed segments and sub-segment of the market are explained below:

By Product:

Non-Absorbents
Absorbents

By Incontinence Type:

Stress Urinary Incontinence
Urge Urinary Incontinence
Overflow Incontinence
Functional Urinary Incontinence
Mixed Urinary Incontinence

By Usage:

Reusable
Disposable

By Distribution Channel:

Offline Stores
Online Channels

By End-use:

Hospitals & Clinics
Homecare
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Male Urinary Incontinence Market Executive Summary

1.1. Global Male Urinary Incontinence Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Incontinence Type
- 1.3.3. By Usage
- 1.3.4. By Distribution Channel
- 1.3.5. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Male Urinary Incontinence Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Male Urinary Incontinence Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Incidences of Urological Disorders
- 3.1.2. Aging Population and Associated Health Issues
- 3.1.3. Increasing Public Awareness
3.2. Market Challenges
- 3.2.1. Complexity in Supply Chain
- 3.2.2. Increasing Generic Competition
3.3. Market Opportunities
- 3.3.1. Advancements in Medical Technology
- 3.3.2. Development of Innovative Products

Chapter 4. Global Male Urinary Incontinence Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Male Urinary Incontinence Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Male Urinary Incontinence Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Non-Absorbents
- 5.2.2. Absorbents

Chapter 6. Global Male Urinary Incontinence Market Size & Forecasts by Incontinence Type 2022-2032

6.1. Segment Dashboard
6.2. Global Male Urinary Incontinence Market: Incontinence Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Stress Urinary Incontinence
- 6.2.2. Urge Urinary Incontinence
- 6.2.3. Overflow Incontinence
- 6.2.4. Functional Urinary Incontinence
- 6.2.5. Mixed Urinary Incontinence

Chapter 7. Global Male Urinary Incontinence Market Size & Forecasts by Usage 2022-2032

7.1. Segment Dashboard
7.2. Global Male Urinary Incontinence Market: Usage Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Reusable
- 7.2.2. Disposable

Chapter 8. Global Male Urinary Incontinence Market Size & Forecasts by Distribution Channel 2022-2032

8.1. Segment Dashboard
8.2. Global Male Urinary Incontinence Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Offline Stores
- 8.2.2. Online Channels

Chapter 9. Global Male Urinary Incontinence Market Size & Forecasts by End-use 2022-2032

9.1. Segment Dashboard
9.2. Global Male Urinary Incontinence Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 9.2.1. Hospitals & Clinics
- 9.2.2. Homecare
- 9.2.3. Others

Chapter 10. Global Male Urinary Incontinence Market Size & Forecasts by Region 2022-2032

10.1. North America Male Urinary Incontinence Market
- 10.1.1. U.S. Male Urinary Incontinence Market
  - 10.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 10.1.1.2. Incontinence Type breakdown size & forecasts, 2022-2032
  - 10.1.1.2. Usage Type breakdown size & forecasts, 2022-2032
  - 10.1.1.2. Distribution Channel Type breakdown size & forecasts, 2022-2032
  - 10.1.1.2. End-use Type breakdown size & forecasts, 2022-2032
- 10.1.2. Canada Male Urinary Incontinence Market
10.2. Europe Male Urinary Incontinence Market
- 10.2.1. U.K. Male Urinary Incontinence Market
- 10.2.2. Germany Male Urinary Incontinence Market
- 10.2.3. France Male Urinary Incontinence Market
- 10.2.4. Spain Male Urinary Incontinence Market
- 10.2.5. Italy Male Urinary Incontinence Market
- 10.2.6. Rest of Europe Male Urinary Incontinence Market
10.3. Asia-Pacific Male Urinary Incontinence Market
- 10.3.1. China Male Urinary Incontinence Market
- 10.3.2. India Male Urinary Incontinence Market
- 10.3.3. Japan Male Urinary Incontinence Market
- 10.3.4. Australia Male Urinary Incontinence Market
- 10.3.5. South Korea Male Urinary Incontinence Market
- 10.3.6. Rest of Asia Pacific Male Urinary Incontinence Market
10.4. Latin America Male Urinary Incontinence Market
- 10.4.1. Brazil Male Urinary Incontinence Market
- 10.4.2. Mexico Male Urinary Incontinence Market
- 10.4.3. Rest of Latin America Male Urinary Incontinence Market
10.5. Middle East & Africa Male Urinary Incontinence Market
- 10.5.1. Saudi Arabia Male Urinary Incontinence Market
- 10.5.2. South Africa Male Urinary Incontinence Market
- 10.5.3. Rest of Middle East & Africa Male Urinary Incontinence Market

Chapter 11. Competitive Intelligence

11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
- 11.3.1. Essity
  - 11.3.1.1. Key Information
  - 11.3.1.2. Overview
  - 11.3.1.3. Financial (Subject to Data Availability)
  - 11.3.1.4. Product Summary
  - 11.3.1.5. Market Strategies
- 11.3.2. Kimberly-Clark Worldwide Inc.
- 11.3.3. Attends Healthcare Products, Inc.
- 11.3.4. ABENA
- 11.3.5. Coloplast Corp.
- 11.3.6. Teleflex Incorporated
- 11.3.7. Boston Scientific Corporation
- 11.3.8. Ontex Healthcare
- 11.3.9. PAUL HARTMANN AG
- 11.3.10. First Quality
- 11.3.11. Medline
- 11.3.12. Hollister Incorporated
- 11.3.13. Cook Medical Incorporated
- 11.3.14. F. Hoffmann-La Roche AG
- 11.3.15. AstraZeneca plc.

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes